Keyword: Drug Development

Webinar

Decoding De Novo Design with Generative Methods

Join us for an insightful webinar on "Decoding De Novo Design with Generative Methods," where we will explore cutting-edge applications of AI/ML to novel molecule design...

Research & Innovation

Fighting Programmed Cell Death

05.06.2024 -

Interview with Morgane Rousselot, SeaBeLife

Research & Innovation

Noncanonical Amino Acids Made by Enzymes

19.03.2024 -

Aralez Bio, a San Francisco-based start-up, has engineered a platform of enzymes that creates 100 times more compound diversity using processes that are also 50 times...

News

Novo Nordisk and Neomorph to Develop Molecular Glue Drugs

04.03.2024 -

US biotechnology company Neomorph signed a $1.46 billion licensing agreement with Novo Nordisk to discover, develop and commercialize molecular glue degraders.

News

Quotient Sciences Bolsters Sterile Fill/Finish Capacity

25.10.2023 -

Quotient Sciences, a drug development and manufacturing accelerator, has invested significantly in expanding its sterile fill/finish capabilities at its Alnwick, UK...

News

Daiichi Sankyo and Merck & Co. Collaborate on Three DXd ADCs Worldwide

20.10.2023 -

Daiichi Sankyo and Merck & Co. to co-develop and commercialize three of Daiichi Sankyo’s DXd antibody-drug conjugate (ADC) candidates worldwide except for Japan where...

Chemistry & Life Sciences

Providing Solutions by Making the Most of Biomedical Data

14.09.2023 -

Many life science companies generate large swathes of data.

Pharma- & Biotech Processing

Lonza Launches PBPK Modelling Service to de-risk Drug Development

Lonza AG -

The new PBPK modelling service from Lonza combines computer models with experiments to predict a molecule’s PK, and whether solubility problems might need solving.